AP Article
FDA Prepares to Reassess Much-Debated Knee Implant
Device maker Regen Biologic challenges FDA plan to reassess highly-contested knee implant
By MATTHEW PERRONE AP Business Writer
WASHINGTON March 19, 2010 (AP) The Associated Press - A medical device company at the center of a highly controversial Food and Drug Administration ("FDA") approval is pushing back against the agency's plan to re-evaluate the implant.
Regen Biologic's knee repair implant spent more than three contentious years under review at the FDA before gaining approval in 2008. When newly appointed Obama administration officials re-examined the approval last year, they concluded that FDA's decision was influenced by intense lobbying by lawmakers from Regen's home state of New Jersey.
FDA is supposed to make decisions based on scientific analysis, but Regen's Menaflex device was cleared despite repeated objections by staff scientists. The two lead FDA officials who oversaw the decision have since left the agency.
Next week the FDA will convene a panel of experts to revisit the safety and effectiveness of the device, an extremely rare step for a device already approved.
Approximately 210 patients in the U.S. and 3,000 in Europe have had Menaflex implanted.
FDA on Friday posted its agenda and discussion questions for the meeting. Regen preemptively responded by questioning the legitimacy of the agency's plans.
"We believe this panel meeting to 're-review' the Menaflex clearance is unprecedented and the FDA has no legal basis," said the company in a statement.
The company also complained that the FDA did not give the company adequate time to review the briefing documents for the meeting.
An FDA spokeswoman said in a statement "the agency has followed standard procedure in scheduling and preparing for this panel meeting."
According to the documents posted to its Web site, FDA plans to ask the panel of orthopedic surgeons about "limitations," with Regen's original application, including missing data.
FDA is not required to follow the guidance of its panels, though it often does.
Hackensack, N.J.-based Regen approached the FDA in 2005 to request its device be approved under the so-called 510k system. Under the procedure, companies can win speedy approval for devices that are similar to products already on the market.
The FDA told the company that its implant did not meet the 510k criteria and would have to go through the traditional approval process - a more expensive, time-consuming process involving clinical testing.
After the FDA twice rejected the company's request for fast-track approval, Regen enlisted the support of New Jersey lawmakers, who called then-FDA Commissioner Andrew von Eschenbach on the company's behalf.
The agency then scheduled a special public meeting to discuss the company's device and ultimately approved it in December 2008.
Hughes Ellzey, LLP
Help for Knee Replacement Patients
Hundreds of people who received a ReGen Menaflex knee implant now face a painful reality - the products in their bodies may be defective and need to be replaced. If you have a ReGen Menaflex knee implant in your body, you should speak with your doctor. Then contact Hughes Ellzey, LLP by calling 1-888-350-3931 for a free case evaluation.
You should also complete the ReGen Menaflex Knee Implant Client Questionnaire and return it to our office as soon as possible. Hughes Ellzey, LLP is currently reviewing cases involving claims for defective medical devices and implants such as the ReGen Menaflex knee implant. ReGen Menaflex knee implant lawyer W. Craft Hughes will work to help you obtain the compensation you deserve. This compensation can include money for replacement surgery, related medical bills, physical therapy, lost of income and pain and suffering.
The content on www.crafthugheslaw.com should NOT be taken as a substitute for advice by a competent attorney or medical professional. The site is sponsored by attorney W. Craft Hughes and the law firm of Hughes Ellzey, LLP, located at 2700 Post Oak Blvd., Suite 1120 Galleria Tower I Houston, TX 77056; Phone 1-888-350-3931. The law firm is licensed to practice in Texas but not elsewhere. On certain mass tort claims, cases may be filed in a state and/or transferred for multi-district litigation to a state other than the client's primary residence. Use of this website or submission of an online form does NOT constitute the forming of an attorney-client relationship. Accordingly, no attorney-client relationship is formed until (1) you are contacted by an attorney from Hughes Ellzey, LLP and (2) you sign a written client agreement. Information contained on www.crafthugheslaw.com, including but not limited to written text, images, informational articles, on-site links and off-site links, has not been prepared, endorsed or reviewed by any form of licensed medical professional, including but not limited to physicians, doctors, medical experts and so on. Nothing on this website should be taken as medical advice, but instead should act as a useful resource in providing general information that may be useful to members of the general public. All visitors are encouraged to consult with a physician or other licensed medical professional for any form of medical advice.
